Dyne 制药 DYN
$18.07 +$0.71 (+4.09%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $18.07 0.00%
开盘$17.68
昨收$17.36
当日区间$17.40 – $18.33
成交量2.36M
市值$3.39B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例100.7%-15.59 个百分点，较上季度
持仓机构数296+2 ，较上季度
内部人近期交易15次买入 / 35次卖出净卖出
空头持仓比例13.64% 占流通股回补天数 7.4 · 截至 15 Oct 2026
卖空成交量占比28.1%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$11.33M（11个净流入日，9个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有41.7%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从11.76%升至13.64%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +311,663 | 0.2% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +250,000 | 0.1% |
| FMR | Mutual Fund | 2026/Q3 | +2,298,020 | 6.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +1,734,919 | 18.7% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +1,405,770 | 0.8% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +1,150,000 | 1.4% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +994,890 | 1.0% |
| Novo Holdings A/S | VC/PE Fund | 2026/Q3 | +960,394 | 0.5% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +942,814 | 0.6% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +804,517 | 4.0% |
| Bank of America Corporation | Public Company | 2026/Q3 | +796,082 | 1.1% |
| BlackRock | Mutual Fund | 2026/Q3 | +704,460 | 6.6% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +597,767 | 1.0% |
| MPM BioImpact LLC | VC/PE Fund | 2026/Q3 | +513,941 | 1.0% |
| Granahan Investment Management, LLC | Mutual Fund | 2026/Q3 | +338,565 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 19 Oct 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Other Acquisition | +8,000 | – | 133,126 |
| 19 Oct 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Other Derivative Acquisition | +12,000 | $16.27 | 12,000 |
| 1 Oct 2026 | Brian Posner | Independent Director | Open Market Acquisition | +2,500 | $16.00 | 27,000 |
| 7 Sep 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Intent to Sell (Form 144) | -35 | $18.89 | – |
| 7 Sep 2026 | John Cox | Chief Executive Officer | Automatic Disposition | -5,658 | $18.88 | 190,274 |
| 7 Sep 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Automatic Disposition | -5,035 | $24.35 | 37,438 |
| 7 Sep 2026 | Johanna Friedl-Naderer | Chief Commercial Officer | Automatic Disposition | -1,085 | $24.35 | 49,931 |
| 3 Sep 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Intent to Sell (Form 144) | -5,000 | $24.35 | – |
| 13 Aug 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -2,586,928 | $26.20 | 3,440,720 | |
| 12 Aug 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Automatic Disposition | -1,556 | $26.28 | 27,598 |
| 12 Aug 2026 | John Cox | Chief Executive Officer | Automatic Disposition | -4,986 | $26.28 | 186,851 |
| 12 Aug 2026 | Erick Lucera | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer | Automatic Disposition | -1,797 | $26.28 | 13,315 |
| 12 Aug 2026 | Johanna Friedl-Naderer | Chief Commercial Officer | Automatic Disposition | -226 | $26.28 | 34,054 |
| 26 Jul 2026 | Forbion Capital Partners B.V. | Automatic Disposition | -261,460 | $26.04 | 3,586,796 | |
| 6 Jul 2026 | Atlas Venture Advisors, Inc. | Open Market Disposition | -5,000 | $23.61 | 6,027,648 | |
| 6 Jul 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -772,451 | $23.62 | 6,027,648 | |
| 28 Jun 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -504,695 | $21.28 | 6,805,099 | |
| 24 Jun 2026 | Erick Lucera | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer | Open Market Disposition | -2,362 | $20.37 | 11,050 |
| 24 Jun 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -267,760 | $21.13 | 7,309,794 | |
| 22 Jun 2026 | Forbion Capital Partners B.V. | Automatic Disposition | -263,962 | $21.47 | 3,848,256 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 25,465,761 | 13.6% | 7.4 |
| 30 Sep 2026 | 25,977,390 | 13.9% | 9.0 |
| 15 Sep 2026 | 23,381,047 | 12.5% | 5.5 |
| 31 Aug 2026 | 20,790,669 | 11.1% | 13.5 |
| 14 Aug 2026 | 21,459,799 | 11.5% | 11.0 |
| 31 Jul 2026 | 21,970,540 | 11.8% | 7.2 |
暂无评论——快来第一个聊聊 DYN。
登录后参与讨论。